SC 13D Filing

Company

Marker Therapeutics, Inc.

Filed

March 17, 2015

Accession Number

0001408408-15-000026

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →